- Home
- RCKT vs DLY Comparison
RCKT vs DLY Comparison
Compare RCKT & DLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCKT
- DLY
- Stock Information
- Founded
- RCKT 1999
- DLY 2019
- Country
- RCKT United States
- DLY United States
- Employees
- RCKT N/A
- DLY N/A
- Industry
- RCKT Biotechnology: Pharmaceutical Preparations
- DLY Investment Managers
- Sector
- RCKT Health Care
- DLY Finance
- Exchange
- RCKT Nasdaq
- DLY Nasdaq
- Market Cap
- RCKT 764.5M
- DLY 703.9M
- IPO Year
- RCKT N/A
- DLY N/A
- Fundamental
- Price
- RCKT $2.77
- DLY $15.67
- Analyst Decision
- RCKT Buy
- DLY
- Analyst Count
- RCKT 11
- DLY 0
- Target Price
- RCKT $21.77
- DLY N/A
- AVG Volume (30 Days)
- RCKT 7.4M
- DLY 215.9K
- Earning Date
- RCKT 05-08-2025
- DLY 01-01-0001
- Dividend Yield
- RCKT N/A
- DLY 8.93%
- EPS Growth
- RCKT N/A
- DLY N/A
- EPS
- RCKT N/A
- DLY N/A
- Revenue
- RCKT N/A
- DLY N/A
- Revenue This Year
- RCKT N/A
- DLY N/A
- Revenue Next Year
- RCKT N/A
- DLY N/A
- P/E Ratio
- RCKT N/A
- DLY N/A
- Revenue Growth
- RCKT N/A
- DLY N/A
- 52 Week Low
- RCKT $2.19
- DLY $13.26
- 52 Week High
- RCKT $26.98
- DLY $15.95
- Technical
- Relative Strength Index (RSI)
- RCKT 27.94
- DLY 61.01
- Support Level
- RCKT $2.19
- DLY $15.30
- Resistance Level
- RCKT $2.67
- DLY $15.59
- Average True Range (ATR)
- RCKT 0.54
- DLY 0.16
- MACD
- RCKT -0.45
- DLY 0.03
- Stochastic Oscillator
- RCKT 11.72
- DLY 78.72
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.
About DLY DoubleLine Yield Opportunities Fund of Beneficial Interest
DoubleLine Yield Opportunities Fund is a diversified, limited-term, closed-end management investment company. Its investment objective is to seek a high level of total return, with an emphasis on current income. The company invests in debt securities and other income-producing investments of issuers anywhere in the world, including in emerging markets, and may invest in investments of any credit quality. Its investment portfolio comprises foreign corporate bonds, foreign government bonds, non-agency commercial mortgage-backed obligations, U.S. corporate bonds, collateralized loan obligations, and bank loans among other securities.